by Maria Zannes | Mar 24, 2022 | Events
Maria Zannes, President & CEO, will discuss keys to a start-up company’s success as part of San Antonio BioMed’s BioFest Invest event on March 30, 2022. Zannes will be on a panel of CEOs presenting to investors, companies and business leaders at the annual spring...
by Maria Zannes | Dec 6, 2021 | Events
bioAffinity discoveries lead to novel approach that kills cancer cells without harm to normal cells by using siRNAs to selectively target multiple cancers DECEMBER 6, 2021 (SAN ANTONIO, TX) bioAffinity Vice President of Research David Elzi, Ph.D., will discuss how...
by Maria Zannes | Oct 14, 2021 | Press Releases
Reveles leads CyPath® Lung, a non-invasive and highly accurate test for lung cancer, as it enters the market OCTOBER 14, 2021 (SAN ANTONIO, TX) bioAffinity Technologies today announced that Xavier T. Reveles, MS, CG, has been promoted to Vice President of Operations....
by Maria Zannes | Sep 29, 2021 | Events
Vice President of Research David Elzi, PhD, will present groundbreaking research leading to bioAffinity’s discovery of how silencing two cell receptors results in cancer cell toxicity, while normal cells are unaffected. His presentation at the American Society of...
by Maria Zannes | Sep 23, 2021 | Press Releases
Australian Patent Office Issues Notice of Acceptance for Patent Related to Porphyrin Compounds and Compositions to Treat Cancer SEPTEMBER 23, 2021 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held biotech company, announced that the Australian Patent Office...
